ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BISGet Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 41,800 shares, a growth of 305.8% from the December 31st total of 10,300 shares. Based on an average trading volume of 12,800 shares, the short-interest ratio is currently 3.3 days.

Institutional Trading of ProShares UltraShort Nasdaq Biotechnology

A hedge fund recently bought a new stake in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new position in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BISFree Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the SEC.

ProShares UltraShort Nasdaq Biotechnology Price Performance

BIS opened at $16.56 on Wednesday. The firm has a 50-day simple moving average of $17.28 and a two-hundred day simple moving average of $15.89. ProShares UltraShort Nasdaq Biotechnology has a 52 week low of $14.05 and a 52 week high of $21.10.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The company also recently declared a dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 23rd were paid a dividend of $0.2064 per share. The ex-dividend date of this dividend was Monday, December 23rd. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

About ProShares UltraShort Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

See Also

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.